... years did not have an overall reduced rate of cardiovascular events, despite a significant lowering of homocysteine ... 6 percent) experienced a confirmed CVD event included in the primary end point (heart ...
... with coronary artery disease, use of B vitamins was not effective for preventing death or cardiovascular events, according to a study published in the August 20 issue of JAMA. "Observational studies ...
... events than the Women Take Heart women. The women who experienced the most frequent cardiovascular events were those with four or more cardiac risk factors.
The physicians hypothesize that this ...
... an association between high levels of markers of inflammation in the circulation with a greater risk of a cardiovascular event, such as a heart attack or stroke. In this study, Naveed Sattar of the ...
... found that 26 percent of the survivors had asymptomatic PAD, and they had three times more subsequent cardiovascular events – stroke, heart attacks or death — in the following two years compared to ...
... whose dentists used a computerized system, "HeartScore," to calculate the risk of a patient dying from a cardiovascular event within a 10-year period.
Designed by the European Society of Cardiology, ...
... benefit or increased harm. Clopidogrel reduced cardiovascular events by 16 percent in men compared ... eight months, clinicians can prevent eight cardiovascular events in women and 12 in men; from a safety ...
... , said: "It has been established that people with RA are more likely to experience cardiovascular disease or complications than the general population, but our research examines the importance of RA- ...
... of data from 16 studies to determine if the ABI provides information on the risk of cardiovascular events and death independently of the FRS and can improve risk prediction. The studies included a ...
... that were too low and led to loss of consciousness, that was a strong predictor of future cardiovascular events.
"The unfavorable findings from the three trials have not been fully realized by the ...
... come from treating the relatively few patients at very high risk who have had a cardiovascular event, who are easy to identify, and who are more likely to be motivated than patients without symptoms, ...
... worldwide have used inhaled tiotropium since its approval.
The increased risk of cardiovascular events and cardiovascular death was particularly manifest in the five long-term trials (longer than 6 ...
... augmentation index, a measure of central arterial stiffness that independently predicts cardiovascular events in high-risk populations, was significantly higher in patients with minimally symptomatic ...
... of therapies commonly prescribed by physicians, and included information about heart attack, stroke or other cardiovascular events. The average age of participants ranged from 52 to 69 and 27 of the ...
... and high levels of hs-CRP, and according to current standards, were not considered "at risk" for cardiovascular events, and were therefore not receiving any treatment. During the study, participants ...
